Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

Why DIANON Sale Alters Anatomic Path Market

LabCorp’s $598 million investment is a major bet on AP-based diagnostics

Another Lab Acquisition: LabCorp To Buy DIANON
“Direct-to-Consumer” Ad Runs in New York Times

CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic pathologists have ample warning that new national competitors will soon attempt to capture local physician accounts. …

Why DIANON Sale Alters Anatomic Path Market Read More »

To access this post, you must purchase The Dark Report.
Another Lab Acquisition: LabCorp To Buy DIANON
“Direct-to-Consumer” Ad Runs in New York Times

Comments

Volume IX No. 16 – November 18, 2002

TABLE OF CONTENTS

COMMENTARY & OPINION BY R. LEWIS DARK

ARTICLES

INTELLIGENCE

Need A Group Membership? Company Discounts are Available!

Get More Information Now!
Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com

© 2024 The Dark Report. All rights reserved.

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

  • This field is for validation purposes and should be left unchanged.
Privacy Policy: We will never share your personal information.